DUBLIN, June 26, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the
"Acute Respiratory Distress Syndrome (ARDS) Forecast in 11 Major
Markets 2017-2027" report to their offering.
Acute respiratory distress syndrome (ARDS) is an acute severe
lung disease. It most often develops in those admitted to an
intensive care unit (ICU), and can be caused by a number of
'triggers', which include trauma to the lungs and pneumonia. ARDS
is characterised by wide-spread diffuse injury to the
alveolar-capillary membrane, pulmonary inflammation and increased
pulmonary vascular permeability. This results in protein-rich
non-cardiogenic pulmonary oedema, refractory hypoxaemia and acute
respiratory failure.
This report provides the current prevalent population for ARDS
across 11 Major Markets (USA,
France, Germany, Italy, Spain,
UK, Japan, Brazil, Poland, Turkey and Netherlands) split by gender and 5-year age
cohort. Along with the current prevalence, the report also contains
a disease overview of the risk factors, disease diagnosis and
prognosis along with specific variations by geography and
ethnicity.
Providing a value-added level of insight from the analysis team,
several of the main symptoms and co-morbidities of ARDS have been
quantified and presented alongside the overall prevalence figures.
These sub-populations within the main disease are also included at
a country level across the 10-year forecast snapshot.
These common ARDS signs and symptoms include:
- Severity as classified by the Berlin definition
- Aetiology of the lung injury
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Disease Prognosis & Clinical Course
6. Methodology for quantification of patient numbers
7. Incidence of ARDS in Hospital Admissions to the ICU
8. Features of ARDS Patients
9. Abbreviations used in the report
10. Patient-Based Offering
11. Online Pricing Data and Platforms
12. References
13. Appendix
For more information about this report visit
https://www.researchandmarkets.com/research/gsgqk6/acute_respiratory
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716